Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from FDA

DEA Shuts Down Drug Factory Even as Adderall Shortage Persists

The DEA is cracking down on manufacturers, hurting patients who genuinely need those drugs.

Jumpstart Your Portfolio With These 3 Biotech Stocks

Jumpstart Your Portfolio With These 3 Biotech Stocks

The biotech industry’s robust growth potential is fueled by scientific advancements, rapid technological adoption, and supportive government initiatives. Thus, you could consider investing in top biotech stocks Exelixis (EXEL), Vertex Pharmaceuticals (VRTX), and Vanda Pharmaceuticals (VNDA) to strengthen your portfolio. Keep reading….

This Could Be the Next Blockbuster Drug Stock to Buy

This Could Be the Next Blockbuster Drug Stock to Buy

Vertex Pharmaceuticals just released data from its experimental drug to relieve pain, with no risk of addiction and very few side effects. This opioid alternative could give Vertex - already a powerhouse in the cystic fibrosis segment - another blockbuster drug to add to its portfolio.

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Trump's quiet federal abortion ban plot

Trump "likes the idea of a 16-week national abortion ban" but wants to keep it quiet, NY Times reports

Experimental Brain Implant Shows Promise In Treating Depression

Learn about Deep Brain Stimulation (DBS) implant for depression treatment, offering hope and relief for patients like Emily Hollenbeck.

3 Mega-Cap Stocks That Could Replace Tesla in the 'Magnificent Seven'

As Tesla stock continues to underperform - now down more than 22% year-to-date - here are 3 mega-cap companies worthy of replacing the beleaguered EV giant in the elite group of mega-cap stocks known as the Magnificent Seven.

FDA Warns Against Using Smartwatches For Blood Glucose Monitoring

FDA warns consumers about potential health risks of using smartwatches for blood glucose monitoring. Stay informed for accurate diabetes management.

inkl

Read news from The Economist, FT, and more,
with one subscription

FDA approves 1st-of-its-kind treatment for severe food allergies

FDA approves 1st-of-its-kind treatment for severe food allergies

The FDA has approved the first drug that can reduce the severity of multiple food allergies at once.

Supreme Court Denies Red State Effort to Intervene in Mifepristone Case

The Court also rejects a late-filed amicus briefs from the American Bar Association, but accepts one from former FDA Commissioners.

1st frostbite drug approved by FDA after successful clinical trial

1st frostbite drug approved by FDA after successful clinical trial

A drug called Aurlumyn has been approved to treat severe frostbite in the U.S. after a successful clinical trial.

Elon Musk's Neuralink has concerning lack of transparency and could be vulnerable to hacking, ethicists warn

Elon Musk's Neuralink has concerning lack of transparency and could be vulnerable to hacking, ethicists warn

Brain-computer interfaces have the potential to transform some people's lives, but they raise a host of ethical issues, too.

FDA Approves First Drug To Treat Food Allergies: Here's What You Need To Know

FDA Approves First Drug To Treat Food Allergies: Here's What You Need To Know

Xolair, a medication initially designed for asthma, has been approved for treating food allergies to prevent severe reactions.

FDA approves a drug to treat severe food allergies, including milk, eggs and nuts

FDA approves a drug to treat severe food allergies, including milk, eggs and nuts

Xolair is considered the first medication approved by the FDA that can help protect against severe allergic reactions brought on by accidental exposure to certain foods.

The CDC investigates a multistate E. coli outbreak linked to raw cheddar cheese

The CDC investigates a multistate E. coli outbreak linked to raw cheddar cheese

Health officials reported 10 cases of E. coli infection, adding that the number of people sick is likely "much higher." Those cases were from California, Colorado, Texas and Utah.

Get all your
news in one place.

100's of premium titles.
One news app.

FDA approves first cell therapy to treat aggressive forms of melanoma

Amtagvi is intended to help patients with melanoma that cannot be removed with surgery or has spread to other parts of the body.

Pharma Stocks Analysis: Grab, Hold, or Sell?

Despite economic pressures and intensified competition, government incentives and drug innovations are fueling growth in the pharma sector. So, let us delve into the analysis of leading pharma stocks Bristol-Myers Squibb (BMY), Collegium Pharmaceutical (COLL), Pfizer (PFE), and Vaxcyte (PCVX), assessing whether to Grab, Hold, or Sell the stocks amid…

FDA approves first-ever drug to treat severe frostbite and "prevent lifechanging amputation of fingers or toes"

Frostbite is an injury to the skin caused when the skin and its underlying tissues freeze, preventing blood, oxygen and nutrients from reaching the affected areas

International Business Times

Mailed Abortion Pills Found To Be Safe Ahead Of US Ruling

Abortions administered as pills sent in the mail are just as safe and effective as those provided in person, a US study said Thursday ahead of a Supreme Court ruling on restricting the medication.

Get all your
news in one place.

100's of premium titles.
One news app.

Abortion pills that patients got via telehealth and the mail are safe, study finds

The study looks at 6,000 patients who got abortion pills after an online appointment. It found that 99.7% of those abortions were not followed by any serious adverse events.

Telehealth abortions are as safe and effective as in-person, large study shows

An analysis of more than 6,000 telehealth abortion recipients in the U.S. suggests that receiving the abortion drugs via a virtual doctor's appointment is as safe and effective as doing so in person.

US FDA Approves First Treatment for Severe Frostbite

The US FDA has approved the first-ever treatment for severe frostbite, a breakthrough for victims of this debilitating condition.

1 Pharma Stock to Buy Near 52-Week Highs

GSK's stock has been a poor performer for years. But recently, the pharma stock keeps setting new 52-week highs, thanks to its blockbuster vaccines.

FDA approves new chemotherapy treatment for pancreatic cancer patients

Learn about the FDA-approved chemotherapy treatment for pancreatic cancer that offers hope to patients, with insights from experts and real-life survivor s...

This device gives you a full health check up in a minute, and it's smaller than a smartphone

The Withings BeamO can be used by up to 8 users in the same household

FDA Warns Online Vendors Selling Misbranded Weight-Loss and Diabetes Drugs

The FDA issues warnings to online vendors selling misbranded weight-loss and diabetes drugs, highlighting potential health risks and illegal practices.

1 … 100 101 102 103

People

181,543 stories

Kritika SarmahHer

Jonathan Mitchell

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

Republican Party

the Supreme Court

Planned Parenthood

the Food and Drug Administration

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

362,282 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play